Abstract
β-Agonists have been shown to display anti-inflammatory properties in several experimental models. The aim of this study was to investigate the anti-inflammatory properties of clenbuterol (CB), administered either intravenously or by aerosol, in comparison with fluticasone propionate (FP) in recurrent airway obstruction (RAO)-susceptible horses. Eight horses, of which five were known to be susceptible to RAO, underwent an inhalation challenge with Aspergillus fumigatus (AF) antigen and were treated with CB intravenously, CB by aerosol, or FP by aerosol. Twenty-four hours after the challenge, bronchoalveolar lavage was performed, the total and differential cell counts were assessed, and cytokines were measured in isolated alveolar macrophages. After challenge with AF, RAO-susceptible horses showed an increase in total cell count, based on an increase in macrophages and lymphocytes, which was inhibited by treatment with intravenous CB, aerosolized CB and aerosolized FP. Neutrophil ratios were decreased when treated with aerosolized CB and FP. Expression of interleukin (IL)-1β and IL −8 was significantly increased after AF challenge .Interleukin −1β was significantly decreased following treatment with intravenous CB, aerosolized CB and aerosolized FP, whereas only FP decreased the expression of IL-8. These data suggest that the anti-inflammatory property of CB provide new opportunities in the therapeutic intervention of early inflammation in RAO.
Similar content being viewed by others
Abbreviations
- AF:
-
Aspergillus fumigatus
- AM:
-
alveolar macrophage(s)
- AR:
-
adrenoceptor
- BAL(F):
-
broncholaveolar lavage (fluid)
- CB:
-
clenbuterol
- DWBC:
-
differential white blood cell count
- FBS:
-
fetal bovine serum
- FP:
-
fluticasone propionate
- GAPDH:
-
glyceraldehyde-3-phosphate dehydrogenase
- IκB:
-
inhibitor κB
- IFN:
-
inter feron
- i.v.:
-
intravenous
- IL:
-
interleukin
- LPS:
-
lipopolysaccharide
- MIP:
-
macrophage inflamatory protein
- NFκB:
-
nuclear factor κB
- PBS:
-
phosphate-buffered saline
- PCR:
-
polymerase chain reaction
- RAO:
-
recurrent airway obstruction
- RPMI:
-
Roswell Park Memorial Institute (medium)
- TLR:
-
Toll-like receptor(s)
- TNF-α:
-
tumor necrosis factor α
- TWBC:
-
total white blood cell count
References
Abraham, G., Brodde, O.E. and Ungemach, F.R., 2002. Regulation of equine lymphocyte beta-adrenoceptors under the influence of clenbuterol and dexamethasone. Equine Veterinary Journal, 34, 587–593
Ainsworth, D.M., Grunig, G., Matychak, M.B., Young, J., Wagner, B., Erb, H.N. and Antczak, D.F., 2003. Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells. Veterinary Immunology and Immunopathology, 96, 83–91
Barnes, P.J., Ito, K. and Adcock, I.M., 2004. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet, 363, 731–733
Dixon, P.M., Railton, D.I., McGorum, B.C. and Tothill, S., 1995. Equine pulmonary disease: a case control study of 300 referred cases. Part 4: Treatments and re-examination findings. Equine Veterinary Journal, 27, 436–439
Farmer, P. and Pugin, J., 2000. β-Adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IκB/NF-κB pathway. American Journal of Physiology. Lung Cellular and Molecular Physiology, 279, L675–682
Fernandez, S., Jose, P., Avdiushko, M.G., Kaplan, A.M. and Cohen, D.A., 2004. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. Journal of Immunology, 172, 2613–2620
Franchini, M., Gilli, U., Akens, M.K., Fellenberg, R.V. and Bracher, V., 1998. The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD). Veterinary Immunology and Immunopathology, 66, 53–65
Giguere, S., Viel, L., Lee, E., MacKay, R.J., Hernandez, J. and Franchini, M., 2002. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Veterinary Immunology and Immunopathology, 85, 147–158
Gizycki, M.J., Hattotuwa, K.L., Barnes, N. and Jeffery, P.K., 2002. Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax, 57, 799–803
Harding, S.M., 1990. The human pharmacology of fluticasone propionate. Respiratory Medicine, 84 (supplement A), 25–29
Hattotuwa, K.L., Gizycki, M.J., Ansari, T.W., Jeffery, P.K. and Barnes, N.C., 2002. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. American Journal of Respiratory and Critical Care Medicine, 165, 1592–1596
Izeboud, C.A., Mocking, J.A., Monshouwer, M., van Miert, A.S. and Witkamp, R.F., 1999a. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. Journal of Receptor and Signal Transduction Research, 19, 191–202
Izeboud, C.A., Monshouwer, M., van Miert, A.S. and Witkamp, R.F., 1999b. The beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo. Inflammation Research, 48, 497–502
Izeboud, C.A., Hoebe, K.H., Grootendorst, A.F., Nijmeijer, S.M., van Miert, A.S., Witkamp, R.R. and Rodenburg, R.J., 2004. Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation. Inflammation Research, 53, 93–99
Jeffery, P.K., Venge, P., Gizycki, M.J., Egerod, I., Dahl, R. and Faurschou, P., 2002. Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study. European Respiratory Journal, 20, 1378–1385
Johnson, M., 2002. Effects of beta2-agonists on resident and infiltrating inflammatory cells. Journal of Allergy and Clinical Immunology, 110, S282–290
Laan, T.T., Westermann, C.M., Dijkstra, A.V., van Nieuwstadt, R.A. and Fink-Gremmels, J., 2004. Biological availability of inhaled fluticasone propionate in horses. Veterinary Record, 155, 361–364
new Laan, T.T.J.M., Bull, S., Pirie, R.S. and Fink-Gremmels, J., 2006. Macrophages in the pathogenesis of recurrent airway obstruction in horses. Journal of Veterinary Internal Medicine, 20, 167–174
Lavoie, J.P., Maghni, K., Desnoyers, M., Taha, R., Martin, J.G. and Hamid, Q.A., 2001. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. American Journal of Respiratory and Critical Care Medicine, 164, 1410–1413
Lentsch, A.B., Czermak, B.J., Bless, N.M., Van Rooijen, N. and Ward, P.A., 1999. Essential role of alveolar macrophages in intrapulmonary activation of NF-κB. American Journal of Respiratory Cell and Molecular Biology, 20, 692–698
Libert, C., Takahashi, N., Cauwels, A., Brouckaert, P., Bluethmann, H. and Fiers, W., 1994. Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. European Journal of Immunology, 24, 2237–2242
Lien, E. and Ingalls, R.R., 2002. Toll-like receptors. Critical Care Medicine, 30, S1–11.
Mair, T.S. and Derksen, F.J., 2000. Chronic obstructive pulmonary disease: a review. Equine Veterinary Education, 12, 35–44
Marr, K.A., Balajee, S.A., Hawn, T.R., Ozinsky, A., Pham, U., Akira, S., Aderem, A. and Liles, W.C., 2003. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infectious Immunology, 71, 5280–5286
McGorum, B.C., Dixon, P.M. and Halliwell, R.E., 1993a. Responses of horses affected with chronic obstructive pulmonary disease to inhalation challenges with mould antigens. Equine Veterinary Journal, 25, 261–267
McGorum, B.C., Dixon, P.M., Halliwell, R.E. and Irving, P., 1993b. Evaluation of urea and albumen as endogenous markers of dilution of equine bronchoalveolar lavage fluid. Research in Veterinary Science, 55, 52–56
Meier, A., Kirschning, C.J., Nikolaus, T., Wagner, H., Heesemann, J. and Ebel, F., 2003. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cellular Microbiology, 5, 561–570
Nakamura, A., Imaizumi, A., Kohsaka, T., Yanagawa, Y. and Johns, E.J., 2000. Beta2-adrenoceptor agonists suppresses tumour necrosis factor production in rat mesangial cells. Cytokine, 12, 491–494
Opal, S.M. and DePalo, V.A., 2000. Anti-inflammatory cytokines. Chest, 117, 1162–1172
Pang, L. and Knox, A.J., 2000. Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. American Journal of Respiratory Cell and Molecular Biology, 23, 79–85
Pirie, R.S., Collie, D.D., Dixon, P.M. and McGorum, B.C., 2002. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves. 2: Effects of inhaled HDS on control and heaves horses. Equine Veterinary Journal, 34, 337–342
Pirie, R.S., Dixon, P.M., Collie, D.D. and McGorum, B.C., 2001. Pulmonary and systemic effects of inhaled endotoxin in control and heaves horses. Equine Veterinary Journal, 33, 311–318
Reid, D.W., Ward, C., Wang, N., Zheng, L., Bish, R., Orsida, B. and Walters, E.H., 2003 Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo. European Respiratory Journal, 21, 994–999
Robinson, N.E., 2001. International Workshop on Equine Chronic Airway Disease. Michigan State University, 16–18 June 2000. Equine Veterinary Journal, 33, 5–19
Roilides, E., Uhlig, K., Venzon, D., Pizzo, P.A. and Walsh, T.J., 1993. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infection and Immunity, 61, 1185–1193
Sherwood, E.R., Varma, T.K., Fram, R.Y., Lin, C.Y., Koutrouvelis, A.P. and Toliver-Kinsky, T.E., 2001. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance. Clinical Science (London), 101, 541–550
Spoelstra, F.M., Postma, D.S., Hovenga, H., Noordhoek, J.A. and Kauffman, H.F., 2002. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax, 57, 237–241
Strieter, R.M., Belperio, J.A. and Keane, M.P., 2003. Host innate defenses in the lung: the role of cytokines. Current Opinion in Infectious Disease, 16, 193–198
Walsh, G.M., Sexton, D.W., and Blaylock, M.G., 2003. Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma. Journal of Endocrinology, 178, 37–43
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X.F. and Achong, M.K., 1998. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. Journal of Clinical Investigation, 101, 311–320
Ye, R.D., 2000. β-Adrenergic agonists regulate NF-κB activation through multiple mechanisms. American Journal of Physiology. Lung Cellular and Molecular Physiology, 279, L615–617
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laan, T.T.J.M., Bull, S., Nieuwstadt, R.A.v. et al. The Effect of Aerosolized and Intravenously Administered Clenbuterol and Aerosolized Fluticasone Propionate on Horses Challenged with Aspergillus fumigatus Antigen. Vet Res Commun 30, 623–635 (2006). https://doi.org/10.1007/s11259-006-3346-9
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11259-006-3346-9